three healthcare workers walk the hall of a hospital

Policy

Top Priorities

On behalf of our members, AdvaMed works on countless fronts to ensure patients have timely access to life-changing technologies. Find out more about our top policy issues.

Regulatory Affairs

PFAS in Medtech

Per- and polyfluoroalkyl substances, known as PFAS, are a broad class of over 12,000 substances that are found in a variety of consumer, commercial and industrial products, including medical devices…

Regulatory Affairs

Artificial Intelligence in Medtech

Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…

Additional Resources

Regulatory Affairs

PFAS in Medtech

Per- and polyfluoroalkyl substances, known as PFAS, are a broad class of over 12,000 substances that are found in a variety of consumer, commercial and industrial products, including medical devices…

Discover More Resources

AdvaMed members have access to our full library of industry resources.

You are not logged in to the AdvaMed Hub.

Medtech: Shaping a New Era in Patient Care

During the last three decades, I have been fortunate to have a unique vantage point of the technological advances transforming patient care and healthcare systems around the world. For the…

Government & Legislative Affairs

AdvaMed Calls on Congress to Prevent Government Shutdown

Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients: 

The MedTech Conference

Six Ways Your Company Can Get Visibility at #Medtechcon

Greetings from AdvaMed, the host of the 2024 MedTech Conference in Toronto, Canada. Understanding how valuable your time and investment are, we’ll help you plan for critical business development at…

Membership Newsletter

We are pleased to provide AdvaMed members with the Membership Newsletter, a monthly publication designed to communicate relevant news, resources, events and policy updates.

Become a member to continue reading. Join AdvaMed

Sign in to access AdvaMed member-only content.

Sign In